Skip to content
Screener

Replimune Group REPL Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$37.8M+24.8%
Candel Therapeutics, Inc. logo
Candel Therapeutics, Inc.CADL
$453K-21.9%
Regenxbio logo
RegenxbioRGNX
$7.36M-8.6%
Immunome logo
ImmunomeIMNM
$152K
CG Oncology logo
CG OncologyCGON
$985K+242%
OnKure Therapeutics, Inc. logo
OnKure Therapeutics, Inc.OKUR
$409K-25.1%

Other financials

Income statement

See full
Operating income-$71.9M-8.9%
Net income-$70.9M-6.9%
EPS (diluted)-$0.77+2.5%

Balance sheet

See full
Cash & equivalents$124.7M-28.3%
Total debt$79.2M+0.5%
Total equity$210.5M-56.4%
Total assets$333.6M-44.7%

Cash flow

See full
Operating cash flow-$66.0M-30.1%
CapEx$135.0K-92.5%
Free cash flow-$66.1M-25.9%

Valuation

See full
Market cap$1.01B+195%
Enterprise value$967.91M+199%

Returns & leverage

See full
Return on equity-90.9%+362pp
Debt / equity0.4×+0.2×
Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The source filing: Replimune Group’s 10-Q, filed February 3, 2026.

Filed
Feb 3, 2026, 8:12 AM EST
Fiscal quarter
Q3 FY2026
Calendar quarter
Q4 2025
Accession
0001628280-26-004805
Line itemDecember 31, 2025March 31, 2025
Current liabilities:
Accounts payable$5,647$12,463
Accrued expenses and other current liabilities40,36545,916
Operating lease liabilities, current1,2131,184
Financing lease liabilities, current2,8622,799
Total current liabilities50,08762,362
Operating lease liabilities, non-current2,5143,076
Financing lease liabilities, non-current22,12922,729

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Replimune Group's operating lease liabilities (current)?
Replimune Group (REPL) reported operating lease liabilities (current) of $1.21M in Q4 2025.
How has Replimune Group's operating lease liabilities (current) changed year-over-year?
Replimune Group's operating lease liabilities (current) increased by 4.2% year-over-year, from $1.16M to $1.21M.
What is the long-term trend for Replimune Group's operating lease liabilities (current)?
Over 4 years (2021 to 2025), Replimune Group's operating lease liabilities (current) has grown at a 5.1% compound annual growth rate (CAGR), from $970K to $1.18M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Ask your AI about Replimune Group's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude